A review of the latest RCTs and meta-analyses on ketamine and esketamine for postpartum depression, including key evidence gaps and practice implications.

KSU alumnus Dr. Ray Rivas went from cash-pay IV ketamine only to nearly 90% insurance-based -- after adding Spravato. Here's his honest account of what worked, what didn't, and what he wishes he'd known sooner.